Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus syntometrine for prevention of postpartum hemorrhage after cesarean section
ACTRN12614000117617Phase 4Completed
- Sponsor
- Ahmed Maged
- Start
- Jun 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Carbetocin with Oxytocin + ergometrine (2 arms). Primary endpoint: Occurrence of postpartum hemorrhage. Started Jun 2011; status: completed.
02
Drugs
carbetocinoxytocinergonovine maleate
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12614000117617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000117617.